Published in J Biol Chem on February 10, 1970
Activity of three murein hydrolases during the cell division cycle of Escherichia coli K-12 as measured in toluene-treated cells. J Bacteriol (1976) 2.49
Murein and the outer penetration barrier of Escherichia coli K-12, Proteus mirabilis, and Pseudomonas aeruginosa. J Bacteriol (1972) 1.95
Lipopolysaccharide layer protection of gram-negative bacteria against inhibition by long-chain fatty acids. J Bacteriol (1973) 1.88
A surface polysaccharide of Escherichia coli O111 contains O-antigen and inhibits agglutination of cells by O-antiserum. J Bacteriol (1982) 1.84
Proteins released from cell envelopes of Pseudomonas aeruginosa on exposure to ethylenediaminetetraacetate: comparison with dimethylformamide-extractable proteins. J Bacteriol (1973) 1.63
The mode of segregation of the bacterial cell membrane. Proc Natl Acad Sci U S A (1972) 1.53
Purification of a Flavobacterium pentachlorophenol-induced periplasmic protein (PcpA) and nucleotide sequence of the corresponding gene (pcpA). J Bacteriol (1991) 1.45
Basis for the observed fluctuation of carboxypeptidase II activity during the cell cycle in BUG 6, a temperature-sensitive division mutant of Escherichia coli. J Bacteriol (1977) 1.13
Lipid content of antibiotic-resistant and -sensitive strains of Serratia marcescens. Appl Microbiol (1972) 1.01
Relation between protein synthesis and phospholipid synthesis and turnover in Escherichia coli. J Bacteriol (1972) 1.01
Active efflux of tetracycline encoded by four genetically different tetracycline resistance determinants in Escherichia coli. Proc Natl Acad Sci U S A (1980) 8.43
Heterogeneity of antigenic-side-chain length in lipopolysaccharide from Escherichia coli 0111 and Salmonella typhimurium LT2. Eur J Biochem (1980) 8.02
Release of lipopolysaccharide by EDTA treatment of E. coli. Biochem Biophys Res Commun (1965) 7.38
Physical, chemical, and immunological properties of lipopolysaccharide released from Escherichia coli by ethylenediaminetetraacetate. J Biol Chem (1968) 7.13
Amplifiable resistance to tetracycline, chloramphenicol, and other antibiotics in Escherichia coli: involvement of a non-plasmid-determined efflux of tetracycline. J Bacteriol (1983) 7.06
Heterogeneity of tetracycline resistance determinants. Plasmid (1980) 6.42
The barrier function of the gram-negative envelope. Ann N Y Acad Sci (1974) 6.08
Studies on the permeability change produced in coliform bacteria by ethylenediaminetetraacetate. J Biol Chem (1968) 6.06
Genetic and functional analysis of the multiple antibiotic resistance (mar) locus in Escherichia coli. J Bacteriol (1993) 6.02
Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction. Antimicrob Agents Chemother (1989) 5.09
marA locus causes decreased expression of OmpF porin in multiple-antibiotic-resistant (Mar) mutants of Escherichia coli. J Bacteriol (1988) 4.97
Fractions of lipopolysaccharide from Escherichia coli O111:B4 prepared by two extraction procedures. J Biol Chem (1975) 4.80
Triclosan targets lipid synthesis. Nature (1998) 4.70
Endogenous active efflux of norfloxacin in susceptible Escherichia coli. Antimicrob Agents Chemother (1988) 4.47
Regulation of chromosomally mediated multiple antibiotic resistance: the mar regulon. Antimicrob Agents Chemother (1997) 4.40
Gene in the major cotransduction gap of the Escherichia coli K-12 linkage map required for the expression of chromosomal resistance to tetracycline and other antibiotics. J Bacteriol (1983) 4.37
Salicylate induction of antibiotic resistance in Escherichia coli: activation of the mar operon and a mar-independent pathway. J Bacteriol (1993) 3.95
Detection of an inducible membrane protein associated with R-factor-mediated tetracycline resistance. Biochem Biophys Res Commun (1974) 3.93
marA, a regulated locus which controls expression of chromosomal multiple antibiotic resistance in Escherichia coli. J Bacteriol (1991) 3.83
Role of the acrAB locus in organic solvent tolerance mediated by expression of marA, soxS, or robA in Escherichia coli. J Bacteriol (1997) 3.81
Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutations. Antimicrob Agents Chemother (2001) 3.62
Survival of rifampin-resistant mutants of Pseudomonas fluorescens and Pseudomonas putida in soil systems. Appl Environ Microbiol (1988) 3.52
The crystal structure of MarR, a regulator of multiple antibiotic resistance, at 2.3 A resolution. Nat Struct Biol (2001) 3.52
Synthesis of an R plasmid protein associated with tetracycline resistance is negatively regulated. Proc Natl Acad Sci U S A (1976) 3.32
Differential expression of over 60 chromosomal genes in Escherichia coli by constitutive expression of MarA. J Bacteriol (2000) 3.27
Changes in intestinal flora of farm personnel after introduction of a tetracycline-supplemented feed on a farm. N Engl J Med (1976) 3.16
Synthesis, utilization and degradation of lactose operon mRNA in Escherichia coli. J Mol Biol (1967) 3.13
Repressor mutations in the marRAB operon that activate oxidative stress genes and multiple antibiotic resistance in Escherichia coli. J Bacteriol (1994) 3.13
The mar regulon: multiple resistance to antibiotics and other toxic chemicals. Trends Microbiol (1999) 2.97
Two complementation groups mediate tetracycline resistance determined by Tn10. J Bacteriol (1982) 2.96
Two mutations which affect the barrier function of the Escherichia coli K-12 outer membrane. J Bacteriol (1979) 2.77
Two transport systems for tetracycline in sensitive Escherichia coli: critical role for an initial rapid uptake system insensitive to energy inhibitors. Antimicrob Agents Chemother (1978) 2.68
Multidrug resistance--a sign of the times. N Engl J Med (1998) 2.68
Spread of antibiotic-resistant plasmids from chicken to chicken and from chicken to man. Nature (1976) 2.67
Overexpression of the marA or soxS regulatory gene in clinical topoisomerase mutants of Escherichia coli. Antimicrob Agents Chemother (1998) 2.59
Frequency of tetracycline resistance determinant classes among lactose-fermenting coliforms. Antimicrob Agents Chemother (1983) 2.58
Characterization of MarR, the repressor of the multiple antibiotic resistance (mar) operon in Escherichia coli. J Bacteriol (1995) 2.55
Plasmid-determined tetracycline resistance involves new transport systems for tetracycline. Nature (1978) 2.50
Mercury released from dental "silver" fillings provokes an increase in mercury- and antibiotic-resistant bacteria in oral and intestinal floras of primates. Antimicrob Agents Chemother (1993) 2.40
Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump. Antimicrob Agents Chemother (2000) 2.40
R factor proteins synthesized in Escherichia coli minicells: incorporation studies with different R factors and detection of deoxyribonucleic acid-binding proteins. J Bacteriol (1974) 2.39
Identification for mar mutants among quinolone-resistant clinical isolates of Escherichia coli. Antimicrob Agents Chemother (1996) 2.34
An equilibrium between two fractions of lipopolysaccharide in Escherichia coli. Proc Natl Acad Sci U S A (1968) 2.33
Segregation of transferable R factors into Escherichia coli minicells. Nature (1970) 2.26
Overexpression of marA, soxS, or acrAB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli. FEMS Microbiol Lett (1998) 2.24
Serum-resistant mutants of Escherichia coli O111 contain increased lipopolysaccharide, lack an O antigen-containing capsule, and cover more of their lipid A core with O antigen. J Bacteriol (1984) 2.12
Alteration of the repressor activity of MarR, the negative regulator of the Escherichia coli marRAB locus, by multiple chemicals in vitro. J Bacteriol (1999) 2.04
Development of an Adhesion Assay and Characterization of an Adhesion-Deficient Mutant of Pseudomonas fluorescens. Appl Environ Microbiol (1990) 1.96
A new tetracycline-resistance determinant, class E, isolated from Enterobacteriaceae. Gene (1986) 1.95
Physical and functional characteristics of R-factor deoxyribonucleic acid segregated into Escherichia coli minicells. J Bacteriol (1971) 1.94
Salmonellae activate complement differentially via the alternative pathway depending on the structure of their lipopolysaccharide O-antigen. J Immunol (1983) 1.90
Very stable prokaryotic messenger RNA in chromosomeless Escherichia coli minicells. Proc Natl Acad Sci U S A (1975) 1.87
Controlling EDTA treatment to produce permeable Escherichia coli with normal metabolic processes. Biochem Biophys Res Commun (1967) 1.85
Carriage of antibiotic-resistant fecal bacteria in Nepal reflects proximity to Kathmandu. J Infect Dis (2001) 1.85
A surface polysaccharide of Escherichia coli O111 contains O-antigen and inhibits agglutination of cells by O-antiserum. J Bacteriol (1982) 1.84
C3 binds preferentially to long-chain lipopolysaccharide during alternative pathway activation by Salmonella montevideo. J Immunol (1986) 1.82
Lipopolysaccharide nomenclature--past, present, and future. J Bacteriol (1986) 1.80
Transport of the lipophilic analog minocycline differs from that of tetracycline in susceptible and resistant Escherichia coli strains. Antimicrob Agents Chemother (1982) 1.80
Resistance of minicells to penicillin lysis: a method of obtaining large quantities of purified minicells. J Bacteriol (1970) 1.79
Role of AcrR and ramA in fluoroquinolone resistance in clinical Klebsiella pneumoniae isolates from Singapore. Antimicrob Agents Chemother (2003) 1.78
Identification of new genes regulated by the marRAB operon in Escherichia coli. J Bacteriol (1995) 1.75
Energy-dependent efflux mediated by class L (tetL) tetracycline resistance determinant from streptococci. Antimicrob Agents Chemother (1987) 1.72
Release of lipopolysaccharide in Escherichia coli resistant to the permeability increase induced by ethylenediaminetetraacetate. J Biol Chem (1970) 1.72
Active efflux of chloramphenicol in susceptible Escherichia coli strains and in multiple-antibiotic-resistant (Mar) mutants. Antimicrob Agents Chemother (1994) 1.71
Non-target gene mutations in the development of fluoroquinolone resistance in Escherichia coli. Antimicrob Agents Chemother (2000) 1.69
A multidrug resistance regulatory chromosomal locus is widespread among enteric bacteria. J Infect Dis (1993) 1.68
Genetic evidence that InhA of Mycobacterium smegmatis is a target for triclosan. Antimicrob Agents Chemother (1999) 1.67
R factor proteins synthesized in Escherichia coli minicells: membrane-associated R factor proteins. J Bacteriol (1974) 1.67
Active uptake of tetracycline by membrane vesicles from susceptible Escherichia coli. Antimicrob Agents Chemother (1981) 1.66
Antimicrobial resistance: a plan of action for community practice. Am Fam Physician (2001) 1.63
Selection of multiple-antibiotic-resistant (mar) mutants of Escherichia coli by using the disinfectant pine oil: roles of the mar and acrAB loci. Antimicrob Agents Chemother (1997) 1.61
Microbial resistance to antibiotics. An evolving and persistent problem. Lancet (1982) 1.60
The transport of diaminopimelate and cystine in Escherichia coli. J Biol Chem (1965) 1.58
Effect of variations in lipopolysaccharide on the fluidity of the outer membrane of Escherichia coli. J Biol Chem (1977) 1.56
Inter- and intraspecies spread of Escherichia coli in a farm environment in the absence of antibiotic usage. Proc Natl Acad Sci U S A (1990) 1.55
Mutational analysis of MarR, the negative regulator of marRAB expression in Escherichia coli, suggests the presence of two regions required for DNA binding. Mol Microbiol (2000) 1.54
Homogeneity of transferable tetracycline-resistance determinants in Haemophilus species. J Infect Dis (1984) 1.54
Multiple antibiotic resistance (mar) locus protects Escherichia coli from rapid cell killing by fluoroquinolones. Antimicrob Agents Chemother (1996) 1.49
Commensals upon us. Biochem Pharmacol (2006) 1.49
Association of organic solvent tolerance and fluoroquinolone resistance in clinical isolates of Escherichia coli. J Antimicrob Chemother (1998) 1.47
Survival of Escherichia coli with and without ColE1::Tn5 after aerosol dispersal in a laboratory and a farm environment. Appl Environ Microbiol (1988) 1.47
Phagocytosis of bacteria by macrophages: changing the carbohydrate of lipopolysaccharide alters interaction with complement and macrophages. J Immunol (1982) 1.45
Biochemical and immunological characterization of an R plasmid-encoded protein with properties resembling those of major cellular outer membrane proteins. J Bacteriol (1980) 1.45
Mode of insertion of lipopolysaccharide into the outer membrane of escherichia coli. J Bacteriol (1976) 1.42
Mechanism of bacterial resistance to complement-mediated killing: inserted C5b-9 correlates with killing for Escherichia coli O111B4 varying in O-antigen capsule and O-polysaccharide coverage of lipid A core oligosaccharide. Infect Immun (1984) 1.42
Competition between congenic Escherichia coli K-12 strains in vivo. Infect Immun (1981) 1.41
In vitro and in vivo antibacterial activities of omadacycline, a novel aminomethylcycline. Antimicrob Agents Chemother (2013) 1.41
Susceptible Escherichia coli cells can actively excrete tetracyclines. Antimicrob Agents Chemother (1983) 1.40
Release of bacteria during the purge cycles of steam-jacketed sterilizers. Br J Biomed Sci (1999) 1.39
Tn5 Insertion Mutants of Pseudomonas fluorescens Defective in Adhesion to Soil and Seeds. Appl Environ Microbiol (1994) 1.37
Antibiotic-resistant bacteria in wild primates: increased prevalence in baboons feeding on human refuse. Appl Environ Microbiol (1985) 1.37
Phenotypic and genotypic characterization of tetracycline- and oxytetracycline-resistant Aeromonas hydrophila from cultured channel catfish (Ictalurus punctatus) and their environments. Appl Environ Microbiol (1988) 1.36
Complement activation by polysaccharide of lipopolysaccharide: an important virulence determinant of salmonellae. Infect Immun (1983) 1.34
A new tetracycline resistance determinant, Tet H, from Pasteurella multocida specifying active efflux of tetracycline. Antimicrob Agents Chemother (1993) 1.30
A soxRS-constitutive mutation contributing to antibiotic resistance in a clinical isolate of Salmonella enterica (Serovar typhimurium). Antimicrob Agents Chemother (2001) 1.28
Intracistronic complementation of the tetracycline resistance membrane protein of Tn10. J Bacteriol (1984) 1.28
Complement activation via the alternative pathway by purified Salmonella lipopolysaccharide is affected by its structure but not its O-antigen length. J Immunol (1984) 1.28